Comparison

EPI·RxISK™ vs Rehand

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

EPI·RxISK™

This tool helps assess cardiovascular risk using multiple risk engines based on patient medical history. It engages patients in managing their risk factors by providing personalized assessments.

Highlights
  • Cardiovascular risk assessment
  • Multiple risk engines
  • Patient engagement
  • Diabetes risk calculation
  • Vascular disease risk calculation
  • Chronic kidney disease risk calculation
Features
Read full description

This calculator is intended as a tool to assess cardiovascular risk and engage patients in managing their risk factors. It uses 4 different risk engines depending on the patient's medical history i.e. if he/she has diabetes, vascular disease, chronic kidney disease or none of those conditions. In the case where more than 1 risk engine could be used (e.g., patient has diabetes and vascular disease), the system will default to using the risk engine generating the highest risk.

About

Rehand

Features
Read full description

Rehand is an intelligent app that supports exercises. With on‑device AI motion analysis, your phone becomes a personal physiotherapy coach. What’s free • Access to trial workouts (a small starter set) • Onboarding and basic guidance • Basic progress view for completed trial workouts • Privacy-first: all motion analysis runs on-device Rehand Premium (subscription) • Full workout library with step‑by‑step guidance • Real‑time AI feedback and live form corrections • Personalized plans adapted to your needs and fitness level • Progress stats, weekly goals, and full session history • Ongoing updates and new workouts Who it’s for • Seniors improving mobility and strength • Anyone building healthy, preventative movement routines Privacy • On‑device processing; your video never leaves your phone • You control your data and can export anytime Medical notice Rehand does not replace professional medical advice. Stop if you feel pain and consult a clinician. Subscription details • Plans available: Weekly, Monthly, Yearly (prices vary by region) • Free trial where available • Auto‑renews unless canceled at least 24 hours before the end of the period • Manage or cancel in your device’s Account Settings after purchase • Privacy Policy: https://rehand.org/privacy • Terms of Use: https://rehand.org/terms • EULA (Apple): https://www.apple.com/legal/internet-services/itunes/dev/stdeula/

Screenshots

EPI·RxISK™4 screens
Rehand4 screens

Verdict

The call

The clearest difference is in-app purchases: EPI·RxISK™ at none against Rehand's 3. EPI·RxISK™ also leads on iOS requirement (10.0 vs 16.0). On price, ads and device support there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. Rehand sells 3 in-app purchases, starting at $14.99 per 7 days. EPI·RxISK™ asks for nothing beyond the download.

Scorecard2 real differences · 7 level
EPI·RxISK™ versus Rehand: the parameters behind the verdict, then further details
ParameterEPI·RxISK™Rehand
PriceFreeFree
Rating5.0 (2 ratings) — better—
Number of ratings2 — better—
Update frequency—Fortnightly
AdsNoNo
In-app purchasesNo — betterYes
MonetizationFree—
DevicesiPhone, iPad, iPod — betteriPhone, iPad
Requires iOS10.0 — better16.0
Further details — not scored
Size19 MB74 MB
Age rating12+17+
DeveloperUniversity of AlbertaSWT Labs

In-app purchases

None

EPI·RxISK™

No in-app purchases

3 purchases

Rehand

Subscriptions3
  • Rehand+ Weekly7 Days trial$14.997 Days
  • Rehand+ Monthly$29.991 Month
  • Rehand+ Yearly$269.001 Year

Questions

Is EPI·RxISK™ free?
EPI·RxISK™ is free to download, with no in-app purchases.
Is Rehand free?
Rehand is free to download, with in-app purchases available.
Do EPI·RxISK™ or Rehand have ads?
Neither EPI·RxISK™ nor Rehand shows ads.

Other comparisons